In North American countries, synthetic folic acid (FA) is overconsumed by pregnant women, and uncertainty exists about its potential unintended health effects. Because the metabolism of FA is different than that of other folate forms, it may modulate disease risk differently. In this episode, Dr. Taren speaks with Dr. Emanuela Pannia and Dr. Rola Hammoud, authors from this month's featured article on their examination of role folate, in its synthetic and bioactive form, as an in utero modifier of metabolic outcomes in mothers and offspring.